Safety and Tolerability Study of E-WE Thrombin in Healthy Adult Subjects
NCT03453060
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
21
Enrollment
INDUSTRY
Sponsor class
Conditions
Thrombosis
Interventions
DRUG:
E-WE Thrombin- Dose 1
DRUG:
E-WE Thrombin- Dose 2
DRUG:
E-WE Thrombin- Dose 3
DRUG:
E-WE Thrombin- Dose 4
OTHER:
Placebo
Sponsor
Aronora, Inc.